Figure 4
Potential mechanisms behind MVI reduction due to antiviral treatment. (a,b) Expression of CK-18, GPC-3, OPN, and pERK determined by immunohistochemistry assays.
Figure 4 | Scientific Reports
Potential mechanisms behind MVI reduction due to antiviral treatment. (a,b) Expression of CK-18, GPC-3, OPN, and pERK determined by immunohistochemistry assays.
